Details
Product Name in the RMS: Cytarabine 100mg/ml
MR Number: NL/H/4561/001
Date of outcome: 16.11.2009
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Abridged Initial Application Generic Chemical Substance Prescription Only |
Active Substances |
cytarabine 100 mg/ml |
Form | solution for injection or infusion |
MA Holder in the RMS |
Accord Healthcare B.V., Winthontlaan 200, 3526 KV Utrecht, Nederland |
RMS | Netherlands |
Date of last change | 18.04.2020 |
ATC-Code |
L01BC01 Cytarabine |
CMS Country | Domestic Product Name |
---|---|
Austria | |
Belgium | |
Bulgaria | Cytarabine Accord |
Cyprus | CYTARABINE ACCORD SOL FOR INF/INJ |
Czech Republic | Cytarabine Accord 100 mg/ml injekční nebo infuzní roztok |
Denmark | Cytarabine "Accord" |
Estonia | CYTARABINE ACCORD 100 MG/ML |
France | |
Germany | Cytarabine Accord 100 mg / ml Lösung zur Injektion oder Infusion |
Hungary | CYTARABINE ACCORD 100 mg/ml oldatos injekció vagy infúzió |
Ireland | |
Italy | |
Latvia | Cytarabine Accord 100 mg/ml šķīdums injekcijām vai infūzijām |
Lithuania | Cytarabine Accord 100 mg/ ml injekcinis/infuzinis tirpalas |
Malta | Cytarabine 10mg/ml solution for injection or infusion |
Norway | |
Portugal | |
Slovak Republic | Cytarabine Accord 100 mg/ml |
Sweden | |
United Kingdom | PL 20075/0121 - 0024 |
Documents | |
---|---|
PAR: | http://www.mhra.gov.uk/home/groups/par/documents/websiteresources/con070968.pdf (20.06.2014) |
FinalLabelling: | NL_H_4561_001_FinalLabelling.pdf (03.06.2019) |